|
G |
Il10 |
interleukin 10 |
treatment |
IDA |
|
RGD |
PMID:24055715 |
RGD:7364866 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:28356392 |
RGD:39457935 |
NCBI chr 7:1,306,320...1,308,434
|
|
G |
Mbl2 |
mannose binding lectin 2 |
severity |
ISO |
|
RGD |
PMID:26745156 |
RGD:11076757 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
IEP |
protein:increased expression:myocardium: |
RGD |
PMID:12435130 |
RGD:10448990 |
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
disease_progression |
ISO |
mRNA:increased expression:heart (mouse) mRNA:increased expression:heart (human) |
RGD |
PMID:29666415 PMID:29666415 PMID:29666415 |
RGD:38599151, RGD:38599151, RGD:38599151 |
NCBI chr 6:54,494,247...54,529,563
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphism:exon (human) |
RGD |
PMID:19811437 |
RGD:5147589 |
NCBI chr20:4,548,664...4,558,237
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
|
RGD |
PMID:16844401 |
RGD:2307145 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
IEP |
|
RGD |
PMID:16844401 |
RGD:2307145 |
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IMP |
|
RGD |
PMID:20452453 |
RGD:4889906 |
NCBI chr10:68,820,330...68,824,906
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
ISO |
|
RGD |
PMID:9148906 |
RGD:5509585 |
NCBI chr 4:65,981,136...66,116,128
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:20699256 PMID:21866301 |
RGD:5147778, RGD:40818435 |
NCBI chr 3:98,051,958...98,065,246
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
|
ISO |
|
RGD |
PMID:21801456 |
RGD:6218957 |
NCBI chr10:37,908,866...37,951,994
|
|
G |
Ifng |
interferon gamma |
|
IDA |
|
RGD |
PMID:10684988 |
RGD:10755744 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il23a |
interleukin 23 subunit alpha |
susceptibility |
ISO |
|
RGD |
PMID:23182712 |
RGD:39457956 |
NCBI chr 7:1,306,320...1,308,434
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
|
ISO |
mRNA:increased expression:plancenta (human) |
RGD |
PMID:29545200 |
RGD:40902989 |
NCBI chr 3:70,062,535...70,066,102
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphisms:exon (human) |
RGD |
PMID:19811437 |
RGD:5147589 |
NCBI chr20:4,548,664...4,558,237
|
|
G |
Soat1 |
sterol O-acyltransferase 1 |
ameliorates |
ISO |
DNA:SNP:exon: rs1044925 (human) |
RGD |
PMID:31236660 |
RGD:126925205 |
NCBI chr13:68,552,274...68,597,529
|
|
G |
Vim |
vimentin |
severity |
IEP ISO |
protein:increased expression:plasma |
RGD |
PMID:22199233 PMID:22199233 |
RGD:6480538, RGD:6480538 |
NCBI chr17:81,577,261...81,585,746
|
|
|
G |
Cat |
catalase |
|
ISO |
protein:decreased activity:erythrocyte: |
RGD |
PMID:9892499 |
RGD:9479188 |
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20102417 |
|
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:12874303 |
RGD:5688168 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:foot, lymph node |
RGD |
PMID:12874303 |
RGD:5688168 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
no_association |
ISO |
DNA:frameshift mutation: :p.S185_T195del (rs333) (human) |
RGD |
PMID:23632983 PMID:17214851 |
RGD:8549764, RGD:8549765 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
mRNA, protein:increased expression:skin of body, blood plasma, CD14-positive monocyte (human) |
RGD |
PMID:32023254 |
RGD:127345130 |
NCBI chr 4:157,085,080...157,118,470
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
|
RGD |
PMID:16358363 |
RGD:41410801 |
NCBI chr 1:236,526,215...236,549,956
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
DNA:SNPs: :rs1061237, rs2586488 (human) |
RGD |
PMID:25562121 |
RGD:11041176 |
NCBI chr10:80,380,458...80,397,461
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:Peripheral blood mononuclear cell: |
RGD |
PMID:29205403 |
RGD:38455981 |
NCBI chr X:17,580,380...17,601,181
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8154019 PMID:9234779 PMID:20102417 PMID:27999013 |
RGD:40890273 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:Peripheral blood mononuclear cell: |
CTD RGD |
PMID:20102417 PMID:29205403 |
RGD:38455981 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il13 |
interleukin 13 |
treatment |
ISO |
|
RGD |
PMID:12739821 PMID:18924210 |
RGD:8549536, RGD:8549561 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
mRNA:increased expression:Peripheral blood mononuclear cell: |
RGD |
PMID:29205403 |
RGD:38455981 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20102417 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:29078003 |
RGD:39457938 |
NCBI chr 7:1,306,320...1,308,434
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20102417 |
|
NCBI chr10:38,272,003...38,277,549
|
|
G |
Klrk1 |
killer cell lectin like receptor K1 |
treatment |
ISO |
associated with lymphocytic choriomeningitis |
RGD |
PMID:26290604 |
RGD:39128165 |
NCBI chr 4:163,079,887...163,092,434
|
|
G |
Lta |
lymphotoxin alpha |
no_association |
ISO |
DNA:SNP:intron:252A>G (human) |
RGD |
PMID:16950634 |
RGD:8548800 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Ltb |
lymphotoxin beta |
|
ISO |
|
RGD |
PMID:17911622 |
RGD:8548820 |
NCBI chr20:3,632,209...3,634,054
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21091666 PMID:21091666 |
RGD:8657030 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Pdcd1lg2 |
programmed cell death 1 ligand 2 |
|
ISO |
|
RGD |
PMID:16358363 |
RGD:41410801 |
NCBI chr 1:227,158,941...227,223,938
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
treatment |
ISO |
|
RGD |
PMID:27999013 |
RGD:40890273 |
NCBI chr 5:165,377,994...165,426,620
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
DNA:insertion/deletion (human) |
RGD |
PMID:20089160 |
RGD:5684930 |
NCBI chr 9:75,957,193...75,968,115
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
protein:increased activity:erythrocyte: |
RGD |
PMID:9892499 |
RGD:9479188 |
NCBI chr11:42,942,742...42,948,399
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
|
RGD |
PMID:10458767 |
RGD:8661703 |
NCBI chr 9:49,472,660...49,588,540
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
protein:decreased expression:skin: |
RGD |
PMID:20493664 |
RGD:7794748 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
protein:decreased expression:skin: |
RGD |
PMID:20493664 |
RGD:7794748 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:decreased expression:skin: |
RGD |
PMID:20493664 |
RGD:7794748 |
NCBI chr 8:115,743,407...115,747,523
|
|
G |
Tnf |
tumor necrosis factor |
no_association |
ISO |
DNA:SNP:promoter:-308G>A (rs1800629) (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20102417 PMID:16950634 |
RGD:8548800 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:25014011 |
RGD:8695986 |
NCBI chr20:4,152,758...4,155,956
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21232540 |
|
NCBI chr 1:22,295,093...22,307,720
|
|
G |
Btk |
Bruton tyrosine kinase |
susceptibility |
ISO |
|
RGD |
PMID:28783468 |
RGD:124715477 |
NCBI chr X:102,016,070...102,055,448
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:15378355 |
RGD:7401274 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10899907 |
RGD:8661227 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
disease_progression |
ISO |
associated with HIV Infections;protein:increased expression:blood, T cell |
RGD |
PMID:10553079 PMID:17457607 |
RGD:8551832, RGD:8551841 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17218153 |
|
NCBI chr13:87,694,062...87,695,978
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
treatment |
ISO |
|
RGD |
PMID:21471446 |
RGD:7771536 |
NCBI chr10:17,184,853...17,187,646
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
treatment |
ISO |
|
RGD |
PMID:21471446 |
RGD:7771536 |
NCBI chr 7:35,979,502...35,983,834
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16540374 PMID:17218153 PMID:2145107 |
RGD:7829781 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16540374 PMID:20404924 |
|
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16879623 PMID:10768930 |
RGD:8655909 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:6224858 |
RGD:8693326 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il21 |
interleukin 21 |
exacerbates |
ISO |
protein:increased expression:popliteal lymph node (mouse) |
RGD |
PMID:22429963 |
RGD:127285547 |
NCBI chr 2:120,117,105...120,127,012
|
|
G |
Il27 |
interleukin 27 |
exacerbates |
ISO |
|
RGD |
PMID:25466588 |
RGD:126790552 |
NCBI chr 1:181,173,108...181,178,720
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:2145107 PMID:2521244 |
RGD:7829781, RGD:7829820 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16540374 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Itgb2 |
integrin subunit beta 2 |
ameliorates |
ISO |
|
RGD |
PMID:14502280 |
RGD:127285813 |
NCBI chr20:11,061,009...11,097,242
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26670606 |
|
NCBI chr 2:185,884,840...185,912,532
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
lupoid leishmaniasis;protein:increased expression:skin of body (human) |
RGD |
PMID:23989888 |
RGD:36947873 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16540374 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf18 |
TNF receptor superfamily member 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20139272 |
|
NCBI chr 5:171,901,734...171,904,578
|
|
G |
Tnfsf4 |
TNF superfamily member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10637281 |
|
NCBI chr13:76,256,654...76,280,133
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
severity |
ISO |
|
RGD |
PMID:24453980 |
RGD:126925972 |
NCBI chr 9:20,259,227...20,276,879
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
RGD |
PMID:17551101 |
RGD:8158083 |
NCBI chr 7:130,864,764...130,916,757
|
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7854095 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
DNA:polymorphism:intron |
RGD |
PMID:7595196 |
RGD:8548799 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
DNA:SNP:promoter:-308G>A (human) |
RGD |
PMID:7595196 |
RGD:8548799 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
IEP |
|
RGD |
PMID:25595977 |
RGD:405650615 |
NCBI chr 6:110,852,188...110,855,054
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
|
IEP |
|
RGD |
PMID:25595977 |
RGD:405650615 |
NCBI chr10:86,190,289...86,191,524
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
protein:altered activity:brain, peritoneal macrophage |
RGD |
PMID:20169057 |
RGD:4891375 |
NCBI chr10:64,313,335...64,349,221
|
|
G |
Pmch |
pro-melanin-concentrating hormone |
|
IEP |
|
RGD |
PMID:25595977 |
RGD:405650615 |
NCBI chr 7:22,511,934...22,513,250
|
|
G |
Tslp |
thymic stromal lymphopoietin |
susceptibility |
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:28769924 |
RGD:38549587 |
NCBI chr18:24,723,990...24,728,419
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
IEP |
|
RGD |
PMID:17722867 |
RGD:10046041 |
NCBI chr 4:154,897,770...154,947,787
|
|
G |
Ada |
adenosine deaminase |
|
IEP |
|
RGD |
PMID:20809996 |
RGD:5128861 |
NCBI chr 3:152,398,745...152,422,854
|
|
G |
Bche |
butyrylcholinesterase |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:20138875 |
RGD:5687328 |
NCBI chr 2:160,607,289...160,699,760
|
|
G |
Cd1d1 |
CD1d1 molecule |
exacerbates |
ISO |
|
RGD |
PMID:15731095 |
RGD:127345115 |
NCBI chr 2:172,423,582...172,427,089
|
|
G |
Hp |
haptoglobin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19567273 |
RGD:11041867 |
NCBI chr19:54,449,151...54,453,701
|
|
G |
Il4 |
interleukin 4 |
treatment |
IEP |
|
RGD |
PMID:24731531 |
RGD:10402804 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:19651871 |
RGD:6482814 |
NCBI chr20:29,246,202...29,251,712
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:18565585 |
RGD:18337478 |
NCBI chr 8:115,743,407...115,747,523
|
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
ISO |
mRNA:altered expression:Bcell,CD4Tcell |
RGD |
PMID:31001826 |
RGD:32716386 |
NCBI chr 4:157,446,120...157,455,958
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21991751 |
RGD:5683905 |
NCBI chr10:68,963,893...68,965,728
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
associated with Malnutrition;mRNA:increased expression:lymph node,spleen: |
RGD |
PMID:24818662 |
RGD:8661728 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
protein:increased expression:blood, T cell |
RGD |
PMID:15379987 |
RGD:6893393 |
NCBI chr 8:123,586,100...123,634,178
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
ISO |
|
RGD |
PMID:24617012 |
RGD:14401738 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cd163 |
CD163 molecule |
exacerbates |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:28355218 |
RGD:127345133 |
NCBI chr 4:157,085,080...157,118,470
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:14573667 |
RGD:8547750 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:14573667 |
RGD:8547750 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10467834 |
|
NCBI chr13:87,694,062...87,695,978
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17404324 PMID:8035028 |
RGD:10449527 |
NCBI chr10:38,887,692...38,889,673
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:16239557 |
RGD:27095947 |
NCBI chr14:15,989,066...15,991,263
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22461696 PMID:23729024 |
RGD:42724459 |
NCBI chr19:13,452,365...13,479,823
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:1901333 PMID:7854095 PMID:3104456 PMID:27999013 |
RGD:8158041, RGD:40890273 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15716043 PMID:17404324 PMID:22461696 PMID:29745990 |
RGD:14975172 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15716043 |
|
NCBI chr 8:54,459,754...54,474,786
|
|
G |
Il18 |
interleukin 18 |
susceptibility |
ISO |
|
RGD |
PMID:16879623 |
RGD:8655922 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17404324 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
mRNA, protein:increased expression:spleen, liver (mouse) |
RGD |
PMID:27245409 |
RGD:126790520 |
NCBI chr 1:181,173,108...181,178,720
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
susceptibility |
ISO |
DNA:polymorphisms:exon:8777, 8838(human) |
RGD |
PMID:17108990 |
RGD:42724466 |
NCBI chr 7:110,033,341...110,048,054
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7554475 PMID:17404324 PMID:22461696 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Irf5 |
interferon regulatory factor 5 |
|
ISO |
protein:increased expression:CD4 T cell, nucleus |
RGD |
PMID:32038622 PMID:30067973 |
RGD:40924560, RGD:40924629 |
NCBI chr 4:59,092,914...59,104,596
|
|
G |
Lta |
lymphotoxin alpha |
severity |
ISO |
DNA:polymorphisms |
RGD |
PMID:12438370 PMID:15579454 |
RGD:8548784, RGD:8548789 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Ltb |
lymphotoxin beta |
|
ISO |
|
RGD |
PMID:12115620 |
RGD:8548822 |
NCBI chr20:3,632,209...3,634,054
|
|
G |
Mbl2 |
mannose binding lectin 2 |
disease_progression susceptibility |
ISO |
protein:increased expression:serum: DNA:SNPs,haplotype:promoter,exon: DNA:polymorphism:promoter: |
RGD |
PMID:17357060 PMID:26297290 PMID:26297290 PMID:22995279 PMID:17357060 |
RGD:8693721, RGD:11522692, RGD:11522692, RGD:8693726, RGD:8693721 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:31182615 |
RGD:21081525 |
NCBI chr11:37,261,114...37,261,178
|
|
G |
Mir21 |
microRNA 21 |
treatment |
ISO |
|
RGD |
PMID:31608064 |
RGD:40925951 |
NCBI chr10:71,902,600...71,902,691
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:23729024 |
RGD:42724459 |
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
treatment |
ISO |
|
RGD |
PMID:27999013 |
RGD:40890273 |
NCBI chr 5:165,377,994...165,426,620
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer: (rs9271858) (human) |
CTD RGD |
PMID:23291585 PMID:23291585 |
RGD:127285406 |
NCBI chr20:4,575,134...4,579,727
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23291585 |
|
NCBI chr20:4,548,664...4,558,237
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16597321 PMID:17067929 |
RGD:5684944 |
NCBI chr 9:75,957,193...75,968,115
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
|
RGD |
PMID:24242758 |
RGD:8661696 |
NCBI chr 9:49,472,660...49,588,540
|
|
G |
Tlr2 |
toll-like receptor 2 |
disease_progression |
ISO |
|
RGD |
PMID:23589575 |
RGD:15090808 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tnf |
tumor necrosis factor |
severity |
ISO |
DNA:polymorphisms CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:1901333 PMID:22461696 PMID:12438370 PMID:15579454 |
RGD:8548784, RGD:8548789 |
NCBI chr20:3,626,685...3,629,303
|
|